Literature DB >> 35129494

Response to: Comment on "Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data".

Zhonghu He1, Fangfang Liu, Wenlei Yang, Yang Ke.   

Abstract

Entities:  

Year:  2021        PMID： 35129494     DOI： 10.1097/SLA.0000000000005281

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  5 in total

1.  ASO Author Reflections: A Novel Blood-Based Predictor (MF-A) That Independently Influences the Prognosis of ESCC Patients Receiving Esophagectomy.

Authors:  Linlin Liang; Fangfang Liu; Zhonghu He; Yang Ke
Journal:  Ann Surg Oncol       Date:  2022-07-11       Impact factor: 4.339

Review 2.  Why pay more for robot in esophageal cancer surgery?

Authors:  Fabrizio Rebecchi; Elettra Ugliono; Marco Ettore Allaix; Mario Morino
Journal:  Updates Surg       Date:  2022-08-11

3.  Implementation of the robotic abdominal phase during robot-assisted minimally invasive esophagectomy (RAMIE): results from a high-volume center.

Authors:  E M de Groot; L Goense; B F Kingma; J W van den Berg; J P Ruurda; R van Hillegersberg
Journal:  Surg Endosc       Date:  2022-10-06       Impact factor: 3.453

4.  Combined Mean Corpuscular Hemoglobin, Fibrinogen, and Albumin (MF-A) Is a Novel Prognostic Marker in Patients with Resectable Esophageal Squamous Cell Carcinoma.

Authors:  Linlin Liang; Fangfang Liu; Wenlei Yang; Wei Yang; Lei Chen; Yu He; Zhen Liu; Liqun Zhang; Fan Zhang; Fen Cai; Huawen Xu; Miaoping Lin; Mengfei Liu; Yaqi Pan; Ying Liu; Zhe Hu; Huanyu Chen; Zhonghu He; Yang Ke
Journal:  Ann Surg Oncol       Date:  2022-02-18       Impact factor: 4.339

5.  Propensity-Matched Analysis of the Short-Term Outcome of Robot-Assisted Minimally Invasive Esophagectomy Versus Conventional Thoracoscopic Esophagectomy in Thoracic Esophageal Cancer.

Authors:  Takeo Fujita; Kazuma Sato; Asako Ozaki; Tomohiro Akutsu; Hisashi Fujiwara; Takashi Kojima; Hiroyuki Daiko
Journal:  World J Surg       Date:  2022-04-30       Impact factor: 3.282
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.